Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Expensify (EXFY) Gains from Investment Securities (2020 - 2025)

Historic Gains from Investment Securities for Expensify (EXFY) over the last 6 years, with Q3 2025 value amounting to $462000.0.

  • Expensify's Gains from Investment Securities fell 6435.19% to $462000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $6.2 million, marking a year-over-year increase of 6645.25%. This contributed to the annual value of $5.1 million for FY2024, which is 2077.48% down from last year.
  • Per Expensify's latest filing, its Gains from Investment Securities stood at $462000.0 for Q3 2025, which was down 6435.19% from $3.8 million recorded in Q2 2025.
  • Expensify's 5-year Gains from Investment Securities high stood at $5.7 million for Q2 2023, and its period low was $12000.0 during Q4 2021.
  • Over the past 5 years, Expensify's median Gains from Investment Securities value was $1.2 million (recorded in 2022), while the average stood at $1.6 million.
  • Within the past 5 years, the most significant YoY rise in Expensify's Gains from Investment Securities was 960000.0% (2022), while the steepest drop was 9345.54% (2022).
  • Expensify's Gains from Investment Securities (Quarter) stood at $12000.0 in 2021, then skyrocketed by 9600.0% to $1.2 million in 2022, then skyrocketed by 392.78% to $5.7 million in 2023, then crashed by 76.69% to $1.3 million in 2024, then crashed by 65.45% to $462000.0 in 2025.
  • Its Gains from Investment Securities was $462000.0 in Q3 2025, compared to $3.8 million in Q2 2025 and $585000.0 in Q1 2025.